Treatment | Page 41 of 465 | SpiritIndia.com

Lung Cancer :: Blood protein detects lung cancer at earliest stage

Biopharmaceutical researchers have found a protein in blood they say is linked to all stages of lung cancer but which rarely shows up in the blood of people without the disease. Testing for this protein might help physicians decide whether smokers or others at high risk for lung cancer should be referred for lung imaging, say investigators, who presented their findings today in Atlanta, Georgia at the American Association for Cancer Research’s second International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

Health :: UT Southwestern earns $34M NIH grant to foster patient-oriented research

UT Southwestern Medical Center will receive $34 million from the National Institutes of Health to lead a wide-ranging collaborative initiative aimed at speeding the transfer of laboratory discoveries to new therapies that improve human health.

Diabetes :: Novartis’ Galvus efficacious in treating patients with type 2 diabetes

Uncontrolled patients with type 2 diabetes treated with metformin, one of the most prescribed oral medicines for this disease, were four times more likely to achieve recommended blood sugar control levels by adding Galvus® (vildagliptin) to their treatment compared to those who added a placebo, according to new clinical data[1].

Osteoporosis :: Aclasta Reclast prevents additional fractures in hip fracture patients with osteoporosis

Results of the first-ever clinical study in patients with osteoporosis who suffered a hip fracture show that a once-yearly infusion of Aclasta®/Reclast® (zoledronic acid 5 mg)[*] reduced the risk of subsequent fractures by 35% compared to patients treated with placebo.

Genetic :: FDA Clears Genetic Lab Test for Warfarin Sensitivity

The U.S. Food and Drug Administration cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.

Tonsil :: Certain tonsil removal technique associated with reduced postoperative pain, bleeding

Patients who have a tonsillectomy using an “intracapsular” technique — which removes at least 90 percent of tonsil tissue, but spares the tonsil capsule — appear to have less postoperative heavy bleeding and pain compared with those who undergo traditional tonsil removal surgery, according to a report in the September issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

Nasal Surgery :: Nasal surgery creates feminine profiles in male-to-female transsexuals

Nasal surgery appears to effectively create feminine facial profiles in patients undergoing male-to-female gender reassignment, according to a report in the September/October issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.

Skin :: Skin cooling associated with increased risk of discoloration after laser treatment

A cooling technique intended to protect the skin may actually increase the risk of discoloration in dark-skinned patients undergoing laser treatments for mole-like skin lesions, according to a report in the September issue of Archives of Dermatology, one of the JAMA/Archives journals.

Head and Neck Cancer :: Patients with head and neck cancer may have impairment of some driving skills

A preliminary study suggests that patients with cancer in the head and neck region may have inferior performance in some driving skills compared with individuals without the disease, according to a report in the September issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

Prostate Cancer :: University of Minnesota study refutes belief that black men have more aggressive prostate cancer

A University of Minnesota study of prostate cancer tumors from Caucasian and African-American men has shown no evidence that the cancer is more aggressive in black men. Lead investigator Akhouri Sinha, a professor of genetics, cell biology, and development and research scientist at the Minneapolis VA Medical Center, said the belief that black men’s tumors are more aggressive is based on studies that failed to match patients properly and used only indirect means to measure tumor aggressiveness.